• Rivaroxaban is indicated for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation • It is used for preventing deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE) in patients undergoing knee or hip replacement surgery. • Rivaroxaban is indicated for reducing the risk of stroke and systemic embolism in patients with

Xarelto film-coated tablets 2.5mg: TABLET, FILM COATED 15 mg/1

Blood - Bone marrow depression. Gastrointestinal - Sudden onset of bleeding into the retroperitoneal space. Liver - Jaundice and liver inflammation. Immune system disorder - Hypersensitivity, anaphylactic reaction and anaphylactic shock. Central Nervous system - Stroke, blood clot in brain and paralysis. Skin - Stevens-Johnson syndrome.

• Patients who use medications like amiodarone, azithromycin, diltiazem, dronedarone, erythromycin, felodipine, quinidine, ranolazine, or verapamil, bleeding problems should be vigilant. • Monitor kidney function, hemoglobin, hematocrit, and blood pressure regularly while taking this medication